Results 281 to 290 of about 1,087,915 (317)
Some of the next articles are maybe not open access.
Fibrolamellar cancer of the liver
Journal of Hepatology, 1987Variete d'hepatomes qui surviennent generalement chez le sujet jeune, progressent moins rapidement que les autres hepatomes et sont frequemment resecables.
openaire +2 more sources
Seminars in Surgical Oncology, 1993
AbstractCryosurgery, the in situ destruction of tissue using subzero temperatures, has been used to treat hepatic metastases. Because it is a focal treatment, cryosurgery can be used in patients with unresectable lesions due to location (next to major blood vessels) or multiplicity.
G M, Onik +3 more
openaire +2 more sources
AbstractCryosurgery, the in situ destruction of tissue using subzero temperatures, has been used to treat hepatic metastases. Because it is a focal treatment, cryosurgery can be used in patients with unresectable lesions due to location (next to major blood vessels) or multiplicity.
G M, Onik +3 more
openaire +2 more sources
Current Oncology Reports, 1997
Hepatocellular carcinoma (HCC) is among the most prevalent and deadly cancers worldwide. Elevated incidence of HCC is strongly associated with hepatitis B virus infection and dietary exposure to hepatotoxic contaminants. Vaccination programs against viral hepatitis hold hope for the eventual reduction of HCC incidence, and screening of cirrhotic ...
Kathryn Z, Guyton, Thomas W, Kensler
openaire +3 more sources
Hepatocellular carcinoma (HCC) is among the most prevalent and deadly cancers worldwide. Elevated incidence of HCC is strongly associated with hepatitis B virus infection and dietary exposure to hepatotoxic contaminants. Vaccination programs against viral hepatitis hold hope for the eventual reduction of HCC incidence, and screening of cirrhotic ...
Kathryn Z, Guyton, Thomas W, Kensler
openaire +3 more sources
Expert Opinion on Pharmacotherapy, 2012
With growing knowledge of the molecular pathway of carcinogenesis, targeted therapies have become the 'blue ocean' of cancer treatment. sorafenib is an oral multikinase inhibitor that targets Raf/mitogen-activated protein (MAP) kinase/extracellular signal-regulated kinase (ERK) (Raf/MEK/ERK) and several tyrosine kinases (VEGFR-2, VEGFR-3, PDGFR-β) that
Hyun Young, Woo, Jeong, Heo
openaire +2 more sources
With growing knowledge of the molecular pathway of carcinogenesis, targeted therapies have become the 'blue ocean' of cancer treatment. sorafenib is an oral multikinase inhibitor that targets Raf/mitogen-activated protein (MAP) kinase/extracellular signal-regulated kinase (ERK) (Raf/MEK/ERK) and several tyrosine kinases (VEGFR-2, VEGFR-3, PDGFR-β) that
Hyun Young, Woo, Jeong, Heo
openaire +2 more sources
Histopathology of liver cancers
Best Practice & Research Clinical Gastroenterology, 2005Recently, new pathomorphologic information about early-stage small hepatocellular carcinoma (HCC) and the multi-step process of human hepatocarcinogenesis has been obtained, along with advances in the development of diagnostic modalities. The most valuable information is that in the majority of cases HCC arises as a very well differentiated cancer and ...
openaire +2 more sources
Clinics in Liver Disease, 2014
Obesity is an established risk factor for many types of cancers, particularly for hepatocellular carcinoma (HCC), owing to its carcinogenic potential and the association with nonalcoholic fatty liver disease (NAFLD). HCC may develop in cirrhotic and noncirrhotic livers with NAFLD, particularly in the presence of multiple metabolic risk factors such as ...
Ester, Vanni, Elisabetta, Bugianesi
openaire +2 more sources
Obesity is an established risk factor for many types of cancers, particularly for hepatocellular carcinoma (HCC), owing to its carcinogenic potential and the association with nonalcoholic fatty liver disease (NAFLD). HCC may develop in cirrhotic and noncirrhotic livers with NAFLD, particularly in the presence of multiple metabolic risk factors such as ...
Ester, Vanni, Elisabetta, Bugianesi
openaire +2 more sources
Clinics and Research in Hepatology and Gastroenterology, 2013
Cancer evolution at all stages (including initiation, progression and invasion) is driven by both epigenetic abnormalities and genetic alterations. Epigenetics refer to any structural modification of genomic regions, which lead to modification in gene expression without alterations in DNA sequence.
Raggi C., Invernizzi P.
openaire +2 more sources
Cancer evolution at all stages (including initiation, progression and invasion) is driven by both epigenetic abnormalities and genetic alterations. Epigenetics refer to any structural modification of genomic regions, which lead to modification in gene expression without alterations in DNA sequence.
Raggi C., Invernizzi P.
openaire +2 more sources
Alcohol, 2003
Mechanisms whereby iron may act in carcinogenesis are induction of oxidative stress, facilitation of tumor growth, and modification of the immune system. Results of clinical and epidemiologic studies demonstrate a strong association between iron excess (even at mild levels) and the development of cancer at any site, but they do not indicate whether ...
openaire +2 more sources
Mechanisms whereby iron may act in carcinogenesis are induction of oxidative stress, facilitation of tumor growth, and modification of the immune system. Results of clinical and epidemiologic studies demonstrate a strong association between iron excess (even at mild levels) and the development of cancer at any site, but they do not indicate whether ...
openaire +2 more sources
Liver Cancer (Primary Liver Cancer, Metastatic Liver Cancer)
2023Yoshiharu Kono +2 more
openaire +1 more source